GENERAL ATLANTIC GENPAR (BERMUDA), L.P. has an estimated net worth of $3.32 Billion. This is based on reported shares across multiple companies, which include EngageSmart, Inc., CinCor Pharma, Inc., Clear Secure, Inc., Mobileye Global Inc., Seaport Therapeutics, Inc., ALKAMI TECHNOLOGY, INC., Genpact LTD, Centessa Pharmaceuticals plc, and HireRight Holdings Corp.

2022 was GENERAL ATLANTIC GENPAR (BERMUDA), L.P.'s most active year for acquiring shares with 23 total transactions. GENERAL ATLANTIC GENPAR (BERMUDA), L.P.'s most active month to acquire stocks was the month of April. 2024 was GENERAL ATLANTIC GENPAR (BERMUDA), L.P.'s most active year for disposing of shares, totalling 9 transactions. GENERAL ATLANTIC GENPAR (BERMUDA), L.P.'s most active month to dispose stocks was the month of December. 2021 saw GENERAL ATLANTIC GENPAR (BERMUDA), L.P. paying a total of $170,895,464.51 for 39,379,612 shares, this is the most they've acquired in one year. In 2024 GENERAL ATLANTIC GENPAR (BERMUDA), L.P. cashed out on 131,526,618 shares for a total of $1,386,367,589.72, their largest year based on trade value.